| 1 | Acetylsalicylic acid | Acetylsalicylic acid 2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,; | 1件: D00109 D00109 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬 |
| 2 | Ambrisentan | Ambrisentan 11件: Ambrisentan; Ambrisentan - high dose; Ambrisentan - low dose; Ambrisentan 5 mg; Ambrisentan 5 mg film-coated tablets; Ambrisentan 5mg film-coated tablets [marketed product]; Ambrisentan plus spironolactone; Ambrisentan tablet; Bosentan, ambrisentan; Tadalafil and ambrisentan upfront combination therapy; Volibris® (ambrisentan); | 1件: D07077 D07077 💬 |
1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
| 3 | Arginine | Ar401959 l-arginine 13件: Ar401959 l-arginine; Arginine; Etrasimod l-arginine; Growth hormone releasing hormone (ghrh) and arginine; L-arginine; Ng-monomethyl-l-arginine; Ng-monomethyl-l-arginine (drug); Other: ghrh plus arginine test; Other: glucose -potentiated arginine (gpa) stimulation tests; Procedure: arginine and clonidine stimulation testing; Procedure: arginine stimulation test after each limb; Procedure: ghrh/arginine stimulation testing; Vasopressin, arginine; | 1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
| 4 | Ascorbic acid | 2l polyethylene glycol/ascorbic acid 5件: 2l polyethylene glycol/ascorbic acid; Ascorbic acid; Ascorbic acid (vitamin c); Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e); Ascorbic acid vit c; | 1件: D00018 D00018 💬 |
- |
- |
010 8件: 10, 97, 192, 206, 210, 211, 212, 298 💬 |
| 5 | Bosentan | Bosentan 18件: Bosentan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan administration; Bosentan and sildenafil; Bosentan group; Bosentan monohidrato; Bosentan monohydrat; Bosentan monohydrate; Bosentan mylan; Bosentan, ambrisentan; Device: nirs after bosentan administration; Device: tcd after bosentan administration; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil 20mg and bosentan 62.5mg; Sildenafil singly or in association with bosentan; | 2件: D01227 D01227
D07538 D07538 💬 |
2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
| 6 | Carvedilol | Carvedilol 2件: Carvedilol; Spironolactone captopril carvedilol; | 2件: D00255 D00255
D03415 D03415 💬 |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 57, 86, 113, 210 💬 |
| 7 | Colchicine | Colchicine 5件: Colchicine; Colchicine 1 mg oral tablet; Colchicine sprinkle capsules; Diagnostic test: colchicine level measurement; Other: colchicine cessation; | 1件: D00570 D00570 💬 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 7件: 2 , 42, 46, 56, 93, 210, 266 💬 |
| 8 | Cow milk | - | - |
- |
- |
098 2件: 98, 210 💬 |
| 9 | Digoxin | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 3件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Digoxin; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | 1件: D00298 D00298 💬 |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 |
Adrenergic signaling in cardiomyocytes 18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
008 3件: 8 , 46, 210 💬 |
| 10 | Enalapril | Enalapril 4件: Enalapril; Enalapril and other angiotensin converting enzyme inhibitors; Enalapril maleate; Enalapril valsartan methylprednisone; | 2件: D00621 D00621
D07892 D07892 💬 |
1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 66, 113, 210, 222, 223 💬 |
| 11 | Eplerenone | Eplerenone 1件: Eplerenone; | 1件: D01115 D01115 💬 |
1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
075 4件: 75, 113, 210, 215 💬 |
| 12 | Horse chestnut | Aesculus hippocastanum / horse chestnut 2件: Aesculus hippocastanum / horse chestnut; Horse chestnut; | - |
- |
- |
210 1件: 210 💬 |
| 13 | Liothyronine | Liothyronine 3件: Liothyronine; Liothyronine i 131; Liothyronine sodium; | 2件: D01011 D01011
D08128 D08128 💬 |
2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
013 4件: 13, 78, 210, 212 💬 |
| 14 | Liothyronine I-131 | - | - |
- |
- |
210 2件: 210, 212 💬 |
| 15 | Macitentan | Act-064992 (macitentan) 15件: Act-064992 (macitentan); Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Macitentan; Macitentan (act-064992); Macitentan 10 mg; Macitentan 10 mg tablet, once daily.; Macitentan 10mg; Macitentan 3 mg; Macitentan 37.5 mg; Macitentan 3mg; Macitentan 75 mg; Macitentan group; Macitentan tablets; Opsumit (macitentan); | 1件: D10135 D10135 💬 |
2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 5件: 51, 85, 86, 88, 210 💬 |
| 16 | Nitric Oxide | Inhaled nitric oxide 14件: Inhaled nitric oxide; Inhaled nitric oxide & inopulse delivery; Inhaled nitric oxide - 30 mcg/kg ibw/hr; Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr; Inhaled nitric oxide 75 mcg/kg ibw/hr; Nitric oxide; Nitric oxide 160 ppm; Nitric oxide for inhalation; Nitric oxide generated by the geno nitrosyl delivery system; Nitric oxide plus oxygen; Nitric oxide supplement; Other: oral nitric oxide testing; Procedure: exhaled nitric oxide; Procedure: exhaled nitric oxide assessment; | 1件: D00074 D00074 💬 |
- |
- |
046 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬 |
| 17 | Rivaroxaban | Lmwh/rivaroxaban 3件: Lmwh/rivaroxaban; Rivaroxaban; Rivaroxaban 20 mg; | 1件: D07086 D07086 💬 |
1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 5件: 46, 49, 75, 91, 210 💬 |
| 18 | Sildenafil | 20 mg sildenafil citrate by mouth 32件: 20 mg sildenafil citrate by mouth; 5% sildenafil cream; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); G04be03- sildenafil - sildenafil (citrato); Mono-therapy with sildenafil; Oral sildenafil; Other: standard of care sildenafil; Sildenafil; Sildenafil (50 mg); Sildenafil (acute-1 hour); Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil (subchronic-4 weeks); Sildenafil 20 mg tablets; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil 40mg oral capsule; Sildenafil and losartan; Sildenafil by injection; Sildenafil citrate; Sildenafil citrate (uk-92,480); Sildenafil filmtabletten; Sildenafil singly or in association with bosentan; Sildenafil therapy; Sildenafilo; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; | 2件: D02229 D02229
D08514 D08514 💬 |
1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
| 19 | Spironolactone | Ambrisentan plus spironolactone 5件: Ambrisentan plus spironolactone; Spironolactone; Spironolactone (drug); Spironolactone and conivaptan; Spironolactone captopril carvedilol; | 1件: D00443 D00443 💬 |
1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
| 20 | Tadalafil | Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) 13件: Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Tadalafil; Tadalafil 20 mg; Tadalafil 20 mg film-coated tablets; Tadalafil 40 mg; Tadalafil and ambrisentan upfront combination therapy; Tadalafil and sildenafil; Tadalafil citrate; Tadalafil oral suspension; Tadalafil, placebo; Tadalafil- tablet or oral suspension; Tadalafilo; | 1件: D02008 D02008 💬 |
1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
| 21 | Treprostinil | Combination product: implantable system for remodulin (treprostinil) 39件: Combination product: implantable system for remodulin (treprostinil); Combination product: treprostinil via implanted pump; Cutaneous iontophoresis of treprostinil; Dietanolamina de treprostinilo; Eutonic treprostinil solution; Hypotonictreprostinil solution; Inhaled dry powder treprostinil (liq861); Inhaled treprostinil; Intravenous treprostinil; Intravenous/subcutaneous treprostinil; Iontophoresis of treprostinil; L606 (liposomal treprostinil) inhalation solution 51ug; Liq861 inhaled treprostinil; Oral treprostinil; Oral treprostinil (ut-15c) sustained release tablets; Parenteral remodulin (treprostinil) injection; Rapid dose titration group of subcutaneous treprostinil; Remodulin (treprostinil sodium); Remodulin® (treprostinil) 1 mg/ml solution for infusion; Remodulin® (treprostinil) 10 mg/ml solution for infusion; Remodulin® (treprostinil) 2.5 mg/ml solution for infusion; Remodulin® (treprostinil) 5 mg/ml solution for infusion; Slow dose titration group of subcutaneous treprostinil; Subcutaneous treprostinil; Treprostinil; Treprostinil dietanolamina; Treprostinil diethanolamine; Treprostinil diolamine; Treprostinil inhalation powder; Treprostinil inhalations; Treprostinil injectable product; Treprostinil sodium; Treprostinil sodium for inhalation; Treprostinil sodium solution for inhalation; Treprostinil sodium, ut-15; Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840; Treprostinilo; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); | 1件: D06213 D06213 💬 |
1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 6件: 51, 84, 85, 86, 88, 210 💬 |
| 22 | Udenafil | Udenafil 1件: Udenafil; | 1件: D10027 D10027 💬 |
1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 2件: 86, 210 💬 |
| 23 | Vasopressin | Vasopressin 2件: Vasopressin; Vasopressin, arginine; | 1件: D00101 D00101 💬 |
3件: AVPR1A, AVPR1B, AVPR2 💬 |
Calcium signaling pathway 5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
210 1件: 210 💬 |